[
  {
    "ts": null,
    "headline": "Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y",
    "summary": "WAT tops Q4 estimates as revenues rise 7% Y/Y, with strong Pharma and Europe growth, and upbeat 2026 sales and earnings outlook.",
    "url": "https://finnhub.io/api/news?id=a0e906919970ce389ca1f6a6be0cb59684b0af4ebf3ee771d5f9c7eecbec4ae0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771006260,
      "headline": "Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y",
      "id": 139089930,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "WAT tops Q4 estimates as revenues rise 7% Y/Y, with strong Pharma and Europe growth, and upbeat 2026 sales and earnings outlook.",
      "url": "https://finnhub.io/api/news?id=a0e906919970ce389ca1f6a6be0cb59684b0af4ebf3ee771d5f9c7eecbec4ae0"
    }
  },
  {
    "ts": null,
    "headline": "Unusual volume S&P500 stocks in Friday's session",
    "summary": "Let's have a look at what is happening on the US markets on Friday. Below you can find the S&P500 stocks with an unusual volume in today's session.",
    "url": "https://finnhub.io/api/news?id=3fb265baa3bcb8489c034990fadeeb51202e0267dcfe2661702ae018e23d2c04",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771005902,
      "headline": "Unusual volume S&P500 stocks in Friday's session",
      "id": 139086968,
      "image": "https://www.chartmill.com/images/uploads/CM_Unusual_Volume_Small_free_b9d2e60841.webp",
      "related": "WAT",
      "source": "ChartMill",
      "summary": "Let's have a look at what is happening on the US markets on Friday. Below you can find the S&P500 stocks with an unusual volume in today's session.",
      "url": "https://finnhub.io/api/news?id=3fb265baa3bcb8489c034990fadeeb51202e0267dcfe2661702ae018e23d2c04"
    }
  },
  {
    "ts": null,
    "headline": "Down 19.0% in 4 Weeks, Here's Why Waters (WAT) Looks Ripe for a Turnaround",
    "summary": "Waters (WAT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.",
    "url": "https://finnhub.io/api/news?id=7ad3671e241dbebc419665181a04b34b2dcf681e8051e6d2ffd3c7e1613dfb24",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770993302,
      "headline": "Down 19.0% in 4 Weeks, Here's Why Waters (WAT) Looks Ripe for a Turnaround",
      "id": 139085258,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "Waters (WAT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.",
      "url": "https://finnhub.io/api/news?id=7ad3671e241dbebc419665181a04b34b2dcf681e8051e6d2ffd3c7e1613dfb24"
    }
  },
  {
    "ts": null,
    "headline": "Becton Dickinson Resets Core Focus With Spin Off And $2b Buyback",
    "summary": "Becton Dickinson (NYSE:BDX) has completed the spin-off of its Biosciences and Diagnostic Solutions businesses, which are being merged with Waters Corporation. The company has launched a $2 billion accelerated share repurchase program alongside the transaction. Generation Investment Management, co founded by Al Gore, has fully exited its position in Becton Dickinson. Becton Dickinson, trading at $177.81, is refocusing on its core MedTech operations after separating its Biosciences and...",
    "url": "https://finnhub.io/api/news?id=1735c207d301a5e8cc2b311e74e10a1ca5b76a205ce8ed71951f5e193ab61a1c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770988162,
      "headline": "Becton Dickinson Resets Core Focus With Spin Off And $2b Buyback",
      "id": 139081417,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "Becton Dickinson (NYSE:BDX) has completed the spin-off of its Biosciences and Diagnostic Solutions businesses, which are being merged with Waters Corporation. The company has launched a $2 billion accelerated share repurchase program alongside the transaction. Generation Investment Management, co founded by Al Gore, has fully exited its position in Becton Dickinson. Becton Dickinson, trading at $177.81, is refocusing on its core MedTech operations after separating its Biosciences and...",
      "url": "https://finnhub.io/api/news?id=1735c207d301a5e8cc2b311e74e10a1ca5b76a205ce8ed71951f5e193ab61a1c"
    }
  },
  {
    "ts": null,
    "headline": "WAT Q4 Deep Dive: Acquisition Integrates BD Biosciences, Margin Pressures Offset Revenue Growth",
    "summary": "Scientific instruments company Waters Corporation (NYSE:WAT) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.8% year on year to $932.4 million. The company expects next quarter’s revenue to be around $1.20 billion, coming in 64.5% above analysts’ estimates. Its non-GAAP profit of $4.53 per share was in line with analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=88e0ed0d9f5892ba33d433483e007f1f78b62c6c06fd544ab6f729466734e3a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770960792,
      "headline": "WAT Q4 Deep Dive: Acquisition Integrates BD Biosciences, Margin Pressures Offset Revenue Growth",
      "id": 139086774,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "Scientific instruments company Waters Corporation (NYSE:WAT) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.8% year on year to $932.4 million. The company expects next quarter’s revenue to be around $1.20 billion, coming in 64.5% above analysts’ estimates. Its non-GAAP profit of $4.53 per share was in line with analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=88e0ed0d9f5892ba33d433483e007f1f78b62c6c06fd544ab6f729466734e3a7"
    }
  }
]